All News

Found 530,511 articles

• Encompass Health to present at 37th Annual J.P. Morgan Healthcare Conference

  12/12/2018

  Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference being held Jan. 7-10, 2019, in San Francisco, California.

• Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines

  12/12/2018

  Good Manufacturing Process (GMP) infrastructure enables advancement of clinical programs through early and mid-phase studies

• Authorized Generic for EVZIO® (naloxone HCl injection) to be Available at a Reduced List Price of $178

  12/12/2018

   Kaléo, a privately-held pharmaceutical company, today announced that it will offer an authorized generic of its EVZIO® (naloxone HCl injection) take home naloxone product at a list price of $178 per carton (each carton contains two auto-injectors).

• Irish Medical Device Start-up Curing Irregular Heart Rhythms Wins the Prestigious ICI Innovation Award

  12/12/2018

  An Irish medical device's company, AuriGen Medical has won the prestigious Global Innovation Award at the ICI conference in Tel Aviv, Israel.

• Crunch Franchise Announces Its Newest Location in Louisville, Kentucky

  12/12/2018

  Crunch Dixie – located in the Dixie Manor shopping center at 6801 Dixie Highway – will be one of the largest Crunch locations nationwide.

• Cresco Labs Co-founder and CEO Charles Bachtell Appointed to Cannabis Legalization Subcommittee of Illinois Governor-elect JB Pritzker’s Transition Team

  12/12/2018

  Cannabis Legalization One of Four Subcommittees Under the Restorative Justice and Safe Communities Transition Committee

• Enzyvant Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development

  12/12/2018

  Enzyvant, a biopharmaceutical company focused on developing therapies for people with rare diseases, today announced the appointment of George O. Elston as Chief Financial Officer and Head of Corporate Development.

• Axiom Foods, One of the Largest Makers of Plant Proteins in U.S., Debuts First Neutral-Flavored Pea and Hemp Proteins For Food Formulators

  12/12/2018

  Food formulators who have been forever scratching their heads to find ways to mask the sharp-green pea and musky hemp protein flavor now have access to the first virtually neutral-tasting pea and hemp protein ingredients this Winter with the launch of Axiom Foods' Cannatein® and Vegotein N™.

• Next Step Bionics & Prosthetics Unveils World’s First Osseointegrated LUKE Arm Prosthesis

  12/12/2018

  First trans-humeral amputee fitted with osseointegrated LUKE arm post targeted muscle reinnervation (TMR) surgery

• AVEO Oncology Announces Immuno-Oncology Clinical Collaboration with AstraZeneca

  12/12/2018

  Phase 1/2 Study will Evaluate Combination of IMFINZI® and FOTIVDA® in First-Line HCC

• Fresenius Medical Care North America Contributes Record Funding to National Kidney Foundation

  12/12/2018

  Fresenius Medical Care North America (FMCNA), the world's largest provider of dialysis products and services, raised more than $800,000 for the National Kidney Foundation (NKF) centerpiece Kidney Walk fundraiser, the nation's largest fundraising initiative to fight kidney disease.

• Owens & Minor Names Robert K. Snead as EVP & Chief Financial Officer

  12/12/2018

  Snead has served as Interim Chief Financial Officer since June 2018

• Sparton Corporation to Be Acquired by Cerberus

  12/12/2018

  Transaction Provides a Significant Premium to Shareholders and a Strong Partner to Support Future Growth

• OncoSec Reports Updated Tumor Responses in KEYNOTE-695 Study of TAVO™ + KEYTRUDA® in Refractory Metastatic Melanoma

  12/12/2018

  OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced an update regarding tumor responses in its KEYNOTE-695 global, multicenter Phase 2b, open-label trial of intratumoral delivery of TAVO

• Trans-Atlantic study finds promising results with Visbiome Vet, a high potency probiotic, in dogs with severe form of acute diarrhea

  12/12/2018

  ExeGi Pharma announced positive results from a recent study conducted at the Clinic of Small Animal Medicine at Ludwig Maximilian University (LMU) in Munich, Germany and the Department of Small Animal Clinical Sciences at Texas A&M University.

• Mallinckrodt's SpecGx LLC Receives FDA Complete Response Letter for Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)

  12/12/2018

  Tablets for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

• Boca Raton Resort & Club, A Waldorf Astoria Resort, And Orangetheory Fitness Announce First Ever Pop-In Residency This Winter

  12/12/2018

  Beginning December 2018 through April 2019, the South Florida Resort will offer unique boutique fitness experiences to guests, making Boca Raton Resort & Club the ultimate wellness getaway

• Walmart and Express Scripts Sign Three-Year Agreement to Deliver Greater Value to Insured and Uninsured Pharmacy Customers

  12/12/2018

  - Today, Walmart and Express Scripts (NASDAQ: ESRX) announced an extension to the companies' existing network agreement to provide access to Walmart's prescription services for Express Scripts clients' covered members. 

• NOVADIP BIOSCIENCES appoints Jeff Abbey as CEO

  12/12/2018

  NOVADIP BIOSCIENCES announces that Jeff Abbey will be appointed chief executive officer, effective early 2019, succeeding Jean-François Pollet.

• Grasp Changing Trends and Seek Industry Prosperity: InnoPack China 2019 to Create Room for Innovation with Every Effort

  12/12/2018

  According to the Global Pharmaceutical Packaging issued by the research institution Freedonia, global pharmaceutical packaging demand is growing by 6% per year and is projected to reach USD112 billion market size in 2021.